OncoHost is a technology company transforming the approach to precision medicine for improved patient outcomes.
OncoHost’s proprietary platform, PROphet®, is a plasma-based, proteomic pattern analysis tool whose initial offering in non-small cell lung cancer (NSCLC) uses a single blood sample to guide first-line immunotherapy decision-making. The PROphet® NSCLC test provides clear clinical utility by offering physicians crucial guidance on the optimal first-line immunotherapy treatment plan for each individual patient, with a significant effect on overall survival.
Led by an experienced team of entrepreneurs and industry experts and supported by a large-scale prospective clinical trial with over 40 sites and 1,700 patients recruited worldwide, OncoHost is well-positioned to lead precision diagnostics and biomarker development to the next stage.
Company Details
- Employees
- 53
- Founded
- -
- Address
- Hamelacha Street 17,
- Phone
- +972 52 333 5429
- Of****@****ost.com
- Industry
- Hospitals And Health Care
- NAICS
-
Health Care and Social AssistanceSocial Assistance
- Website
- oncohost.com
- Keywords
- Representative jobs.
- HQ
- Binyamina, Israel
Oncohost Questions
Oncohost's helpline number is +972 52 333 5429
Oncohost's website is oncohost.com
Oncohost's LinkedIn profile is https://www.linkedin.com/company/oncohost
Oncohost has
53 employees.
View email and phone details for 53
employees at Oncohost.
Oncohost's industry is
Hospitals and Health Care
Oncohost's top competitors are
Immunai,
Memed,
Polypid Ltd.,
Novocure,
Nucleai,
Cytoreason,
Navina,
Enzymit,
Imagene,
Medisafe®.
Oncohost's support email address is Ofer@OncoHost.com
Oncohost's categories are Hospitals and Health Care
Oncohost's founding year is 2017
